These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 6277187)
1. The middle molecule hypothesis in perspective. Babb AL; Ahmad S; Bergström J; Scribner BH Am J Kidney Dis; 1981 Jul; 1(1):46-50. PubMed ID: 6277187 [TBL] [Abstract][Full Text] [Related]
2. [Medium-sized molecules and the process of uremic intoxication]. Lutz W Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302 [No Abstract] [Full Text] [Related]
3. Uremic toxins and peritoneal dialysis. Lameire N; Vanholder R; De Smet R Kidney Int Suppl; 2001 Feb; 78():S292-7. PubMed ID: 11169029 [TBL] [Abstract][Full Text] [Related]
4. Nervous system complications in uremia. Fraser CL; Arieff AI Ann Intern Med; 1988 Jul; 109(2):143-53. PubMed ID: 2837930 [TBL] [Abstract][Full Text] [Related]
6. Do middle molecules cause uremic intoxication? (Con). Kjellstrand CM Am J Kidney Dis; 1981 Jul; 1(1):51-6. PubMed ID: 7332001 [TBL] [Abstract][Full Text] [Related]
7. [Neuropathy and encephalopathy in dialysis treatment]. Miyahara T; Shimojo S; Iwazawa A; Miyashima T; Yanagisawa O Nihon Rinsho; 1972 Dec; 30(12):2521-8. PubMed ID: 4347357 [No Abstract] [Full Text] [Related]
8. Screening for peripheral neuropathy in patients treated by chronic hemodialysis. Thomas PK Muscle Nerve; 1978; 1(5):396-9. PubMed ID: 233738 [TBL] [Abstract][Full Text] [Related]
9. A case of an accelerated uremic neuropathy. Deger SM; Reis KA; Guz G; Bali M; Erten Y Ren Fail; 2011; 33(3):371-2. PubMed ID: 21401366 [TBL] [Abstract][Full Text] [Related]
10. Membranes and their removal of uremic toxins. Hoenich NA Adv Exp Med Biol; 1987; 223():253-62. PubMed ID: 3447443 [No Abstract] [Full Text] [Related]
11. A dialyzable toxic factor in uremia. Lonergan ET; Semar M; Lange K Trans Am Soc Artif Intern Organs; 1970; 16():269-71. PubMed ID: 4318263 [No Abstract] [Full Text] [Related]
12. [Uremic neuropathy and the type of dialysis]. Firenze C; Gallai V; Mattelli L; Mazzotta G; Panzetta AM; Buoncristiani U Riv Patol Nerv Ment; 1982; 103(6):271-6. PubMed ID: 6326249 [TBL] [Abstract][Full Text] [Related]
13. [Uremic middle-molecule toxins and their removal in hemofiltration]. Kazakov IV; Timokhov VS Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215 [No Abstract] [Full Text] [Related]
14. History of sorbents in uremia. Winchester JF; Ronco C; Brady JA; Clemmer J; Muller TE; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Levin NW Contrib Nephrol; 2001; (133):131-9. PubMed ID: 11477746 [No Abstract] [Full Text] [Related]
16. The Middle Molecule Hypothesis Revisited. Should Short, Three Times Weekly Hemodialysis Be Abandoned? Charra B; Scribner BH; Twardowski ZJ; Bergström J Hemodial Int; 2002 Jan; 6(1):9-14. PubMed ID: 28455930 [TBL] [Abstract][Full Text] [Related]
17. Editorial: Neuropathy in uremic patients on dialysis. Tyler HR N Engl J Med; 1975 May; 292(20):1075. PubMed ID: 164626 [No Abstract] [Full Text] [Related]
18. [Uremic neuropathy. Study of the motor conduction rate in patients treated with maintenance hemodialysis and peritoneal dialysis]. Cianchetti C; Carobi C; Perticoni G; Buoncristiani U Riv Neurol; 1977; 47(1):83-104. PubMed ID: 193173 [TBL] [Abstract][Full Text] [Related]
19. Short dialysis, middle molecules, and uremia. Nolph KD Ann Intern Med; 1977 Jan; 86(1):93-7. PubMed ID: 835933 [TBL] [Abstract][Full Text] [Related]
20. Polyneuropathy in patients with uraemia treated with dialysis. Pakkenberg H; Christoffersen P; Nielsen B; Larsen NA Acta Neurol Scand; 1970; 46(S43):206. PubMed ID: 4318674 [No Abstract] [Full Text] [Related] [Next] [New Search]